These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10196309)

  • 61. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.
    Roy S; Delling U; Chen CH; Rosen CA; Sonenberg N
    Genes Dev; 1990 Aug; 4(8):1365-73. PubMed ID: 2227414
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
    Endo-Munoz L; Warby T; Harrich D; McMillan NA
    Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombination.
    Nikolaitchik O; Rhodes TD; Ott D; Hu WS
    J Virol; 2006 May; 80(10):4691-7. PubMed ID: 16641262
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
    Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R
    J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rev-free HIV-1 gene delivery system for targeting Rev-RRE-Crm1 nucleocytoplasmic RNA transport pathway.
    Srinivasakumar N
    PLoS One; 2011; 6(12):e28462. PubMed ID: 22164294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription.
    Das AT; Harwig A; Vrolijk MM; Berkhout B
    J Virol; 2007 Jul; 81(14):7742-8. PubMed ID: 17494072
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mutational analysis of the predicted secondary RNA structure of the Mason-Pfizer monkey virus packaging signal.
    Mustafa F; Lew KA; Schmidt RD; Browning MT; Rizvi TA
    Virus Res; 2004 Jan; 99(1):35-46. PubMed ID: 14687944
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of a minimal region of the HIV-1 5'-leader required for RNA dimerization, NC binding, and packaging.
    Heng X; Kharytonchyk S; Garcia EL; Lu K; Divakaruni SS; LaCotti C; Edme K; Telesnitsky A; Summers MF
    J Mol Biol; 2012 Mar; 417(3):224-39. PubMed ID: 22306406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.
    Liang C; Rong L; Russell RS; Wainberg MA
    J Virol; 2000 Jul; 74(14):6251-61. PubMed ID: 10864634
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIV-1 suppressive sequences are modulated by Rev transport of unspliced RNA and are required for efficient HIV-1 production.
    Noguchi K; Ishibashi K; Miyokawa K; Hokari M; Kanno T; Hirano T; Yamamoto N; Takaku H
    PLoS One; 2012; 7(12):e51393. PubMed ID: 23251516
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation.
    Schneider R; Campbell M; Nasioulas G; Felber BK; Pavlakis GN
    J Virol; 1997 Jul; 71(7):4892-903. PubMed ID: 9188551
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation.
    Anderson EC; Lever AM
    J Virol; 2006 Nov; 80(21):10478-86. PubMed ID: 17041220
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of human immunodeficiency virus type 1 RNA dimerization on viral infectivity and of stem-loop B on RNA dimerization and reverse transcription and dissociation of dimerization from packaging.
    Shen N; Jetté L; Liang C; Wainberg MA; Laughrea M
    J Virol; 2000 Jun; 74(12):5729-35. PubMed ID: 10823883
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antiviral activity of steric-block oligonucleotides targeting the HIV-1 trans-activation response and packaging signal stem-loop RNAs.
    Brown D; Arzumanov AA; Turner JJ; Stetsenko DA; Lever AM; Gait MJ
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):393-6. PubMed ID: 16247957
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular cloning and characterization of a TAR-binding nuclear factor from T cells.
    Reddy TR; Suhasini M; Rappaport J; Looney DJ; Kraus G; Wong-Staal F
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):663-9. PubMed ID: 7576925
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Unusual structure of the human immunodeficiency virus type 1 trans-activation response element.
    Colvin RA; Garcia-Blanco MA
    J Virol; 1992 Feb; 66(2):930-5. PubMed ID: 1731114
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.
    Kaye JF; Lever AM
    J Virol; 1998 Jul; 72(7):5877-85. PubMed ID: 9621049
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Deficient dimerization of human immunodeficiency virus type 1 RNA caused by mutations of the u5 RNA sequences.
    Russell RS; Hu J; Laughrea M; Wainberg MA; Liang C
    Virology; 2002 Nov; 303(1):152-63. PubMed ID: 12482667
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The human immunodeficiency virus type 1 5' packaging signal structure affects translation but does not function as an internal ribosome entry site structure.
    Miele G; Mouland A; Harrison GP; Cohen E; Lever AM
    J Virol; 1996 Feb; 70(2):944-51. PubMed ID: 8551634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.